EUR 177.8
(1.14%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 1.02 Billion EUR | 0.35% |
2022 | 1.02 Billion EUR | 12.67% |
2021 | 905.59 Million EUR | 30.29% |
2020 | 695.07 Million EUR | 20.33% |
2019 | 577.65 Million EUR | 14.85% |
2018 | 502.98 Million EUR | 13.31% |
2017 | 443.88 Million EUR | 15.56% |
2016 | 384.12 Million EUR | 12.95% |
2015 | 340.09 Million EUR | 13.57% |
2014 | 299.47 Million EUR | -1.93% |
2013 | 305.36 Million EUR | 3.68% |
2012 | 294.52 Million EUR | 11.44% |
2011 | 264.29 Million EUR | 10.55% |
2010 | 239.07 Million EUR | -3.75% |
2009 | 248.39 Million EUR | 8.23% |
2008 | 229.51 Million EUR | 2.76% |
2007 | 223.34 Million EUR | 16.62% |
2006 | 191.52 Million EUR | 4.95% |
2005 | 182.49 Million EUR | -0.43% |
2004 | 183.28 Million EUR | -3.18% |
2003 | 189.31 Million EUR | -2.8% |
2002 | 194.77 Million EUR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 240.3 Million EUR | -4.79% |
2024 Q1 | 252.4 Million EUR | 46.92% |
2024 Q3 | 276.9 Million EUR | 15.23% |
2023 Q3 | 279.9 Million EUR | -0.57% |
2023 Q4 | 171.8 Million EUR | -38.62% |
2023 FY | 1.02 Billion EUR | 0.35% |
2023 Q1 | 290.8 Million EUR | 32.6% |
2023 Q2 | 281.5 Million EUR | -3.2% |
2022 Q2 | 257.6 Million EUR | -0.73% |
2022 Q4 | 219.3 Million EUR | -22.7% |
2022 Q1 | 259.5 Million EUR | 18.12% |
2022 FY | 1.02 Billion EUR | 12.67% |
2022 Q3 | 283.7 Million EUR | 10.13% |
2021 Q3 | 248.9 Million EUR | 10.57% |
2021 Q4 | 219.69 Million EUR | -11.74% |
2021 FY | 905.59 Million EUR | 30.29% |
2021 Q1 | 211.9 Million EUR | 42.05% |
2021 Q2 | 225.1 Million EUR | 6.23% |
2020 FY | 695.07 Million EUR | 20.33% |
2020 Q1 | 174.7 Million EUR | 16.97% |
2020 Q2 | 185.2 Million EUR | 6.01% |
2020 Q3 | 185.3 Million EUR | 0.05% |
2020 Q4 | 149.17 Million EUR | -19.5% |
2019 Q4 | 149.35 Million EUR | -3.08% |
2019 FY | 577.65 Million EUR | 14.85% |
2019 Q2 | 149.1 Million EUR | 3.9% |
2019 Q1 | 143.5 Million EUR | 16.87% |
2019 Q3 | 154.1 Million EUR | 3.35% |
2018 Q3 | 132.6 Million EUR | -0.97% |
2018 FY | 502.98 Million EUR | 13.31% |
2018 Q4 | 122.78 Million EUR | -7.4% |
2018 Q2 | 133.9 Million EUR | 0.98% |
2018 Q1 | 132.6 Million EUR | 49.35% |
2017 FY | 443.88 Million EUR | 15.56% |
2017 Q4 | 88.78 Million EUR | -27.17% |
2017 Q3 | 121.9 Million EUR | 2.18% |
2017 Q2 | 119.3 Million EUR | 4.74% |
2017 Q1 | 113.9 Million EUR | 42.15% |
2016 Q4 | 80.12 Million EUR | -26.35% |
2016 FY | 384.12 Million EUR | 12.95% |
2016 Q3 | 108.8 Million EUR | 12.98% |
2016 Q2 | 96.3 Million EUR | -2.63% |
2016 Q1 | 98.9 Million EUR | 46.1% |
2015 Q1 | 83.5 Million EUR | 70.86% |
2015 Q3 | 95.7 Million EUR | 2.68% |
2015 Q4 | 67.69 Million EUR | -29.26% |
2015 FY | 340.09 Million EUR | 13.57% |
2015 Q2 | 93.2 Million EUR | 11.62% |
2014 Q2 | 84.4 Million EUR | 3.56% |
2014 FY | 299.47 Million EUR | -1.93% |
2014 Q4 | 48.87 Million EUR | -42.23% |
2014 Q3 | 84.6 Million EUR | 0.24% |
2014 Q1 | 81.5 Million EUR | 17.83% |
2013 Q4 | 69.16 Million EUR | -10.64% |
2013 FY | 305.36 Million EUR | 3.68% |
2013 Q3 | 77.4 Million EUR | -5.38% |
2013 Q2 | 81.8 Million EUR | 6.1% |
2013 Q1 | 77.1 Million EUR | 26.35% |
2012 FY | 294.52 Million EUR | 11.44% |
2012 Q4 | 61.02 Million EUR | -20.85% |
2012 Q1 | 77.8 Million EUR | 17.54% |
2012 Q2 | 78.5 Million EUR | 0.9% |
2012 Q3 | 77.1 Million EUR | -1.78% |
2011 Q3 | 63.8 Million EUR | -10.89% |
2011 Q4 | 66.19 Million EUR | 3.75% |
2011 Q1 | 62.6 Million EUR | 4.03% |
2011 Q2 | 71.6 Million EUR | 14.38% |
2011 FY | 264.29 Million EUR | 10.55% |
2010 Q3 | 60.4 Million EUR | -2.42% |
2010 FY | 239.07 Million EUR | -3.75% |
2010 Q1 | 57.1 Million EUR | -1.55% |
2010 Q2 | 61.9 Million EUR | 8.41% |
2010 Q4 | 60.17 Million EUR | -0.38% |
2009 Q3 | 58.4 Million EUR | -21.29% |
2009 FY | 248.39 Million EUR | 8.23% |
2009 Q1 | 57.7 Million EUR | 0.0% |
2009 Q2 | 74.2 Million EUR | 28.6% |
2009 Q4 | 57.99 Million EUR | -0.69% |
2008 FY | 229.51 Million EUR | 2.76% |
2007 FY | 223.34 Million EUR | 16.62% |
2006 FY | 191.52 Million EUR | 4.95% |
2005 FY | 182.49 Million EUR | -0.43% |
2004 FY | 183.28 Million EUR | -3.18% |
2003 FY | 189.31 Million EUR | -2.8% |
2002 FY | 194.77 Million EUR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
SCHOTT Pharma AG & Co. KGaA | 124.1 Million EUR | -723.892% |
Carl Zeiss Meditec AG | 878.62 Million EUR | -16.374% |
Fielmann Aktiengesellschaft | 289.86 Million EUR | -252.75% |
Gerresheimer AG | 383.92 Million EUR | -166.329% |
Sartorius Aktiengesellschaft | 1.02 Billion EUR | 0.137% |